Login / Signup

Persistent subretinal fluid following tractional retinal detachment repair: An exploring use of dexamethasone implant.

Xinyuan HuangYan ShaoXiao-Rong Li
Published in: European journal of ophthalmology (2022)
Dexamethasone implant can be an option for effective treatment of persistent SRF after TRD repair, especially in some refractory cases. However, the mechanism remains unclear, and the treatment regimen needs to be explored based on more clinical trials.
Keyphrases
  • clinical trial
  • high dose
  • randomized controlled trial
  • soft tissue
  • combination therapy
  • replacement therapy
  • open label